Q3 FY2026 · ended Sep 30, 2026 · Revenue $6.52B, +7.6% YoY · Filed Oct 30, 2026
Stryker Corp (SYK) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $6.5 billion and net income of $753.0 million. Free cash flow was $1.2 billion. As of Sep 30, 2026 it held $3.3 billion in cash and investments and $15.7 billion in total debt.
Revenue
$6.52B
+7.6% vs year-ago quarter
Net income
$753.00M
-12.3% vs year-ago quarter
Operating cash flow
$1.46B
-5.1% vs year-ago quarter
Free cash flow
$1.22B
-9.5% vs year-ago quarter
EPS
$1.96
-11.7% vs year-ago quarter
Dividend per share
$0.88
+4.8% vs year-ago quarter
Shares outstanding
380.69M
-0.5% vs year-ago quarter
Net cash
$-12.41B
Q3 FY2026
Operating margin
20.7%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SYK (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- MI
- Headquarters
- Portage, MI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 310764
Other Surgical & Medical Instruments & Apparatus companies
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $6.5B | $6.6B | $6.0B | $7.2B | $6.1B |
| Operating income | $1.0B | $1.7B | $936.0M | $1.8B | $1.1B |
| Net income | $753.0M | $1.3B | $745.0M | $849.0M | $859.0M |
| Diluted EPS | $1.96 | $3.30 | $1.93 | $2.20 | $2.22 |
| Operating cash flow | $1.5B | $1.3B | $581.0M | $2.1B | $1.5B |
| Free cash flow | $1.2B | $1.1B | $415.0M | $1.9B | $1.4B |
| Total assets | $47.2B | $47.9B | $46.3B | $47.8B | $47.1B |
| Total liabilities | $23.8B | $23.9B | $23.3B | $25.4B | $25.3B |
| Stockholders' equity | $23.5B | $24.0B | $23.0B | $22.4B | $21.8B |
| Cash and investments | $3.3B | $3.5B | $3.0B | $4.1B | $3.3B |
| Total debt | $15.7B | $15.7B | $15.2B | $16.4B | $17.1B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Other events
|
Jun 26, 2026 | Jun 26, 2026 |
All 1000 Stryker Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.